IBD Anniversary OfferIBD Anniversary Offer


Autodesk Posts Surprise Profit; Splunk, Ulta Beauty Beat

Autodesk, Splunk and Ulta Beauty will report after the close Thursday. (Coolcaesar)

Autodesk (ADSK) topped forecasts and guided full-year results above views, while Splunk (SPLK) and Ulta Beauty (ULTA) also beat estimates.

Autodesk

Estimates: A Q2 net loss of 13 cents a share, with revenue down 16% to $512.07 million.

Results: Adjusted EPS of 5 cents on revenue of $551 million.

Outlook: Q3 adjusted loss of 27-22 cents a share, better than views for a loss of 28 cents, on revenue of $470 million-$485 million, above consensus for $468.5 million; full-year adjusted loss of 70-55 cents a share vs. consensus for per-share loss of 82 cents. Net subscription additions seen at 475,000- 525,000 for the year.

Stock: Shares rallied 3.6% after hours on the stock market today.

Autodesk's software helps businesses in areas like manufacturing and construction develop and test the things they make. As IBD noted this week, the company has tried to move toward subscriptions and more flexible license agreements.

Splunk

Estimates: Analysts expect fiscal second-quarter 2017 earnings per share of 3 cents, the same as what the company reported a year ago. Revenue for the data analytics software company is seen jumping 35% to $200.5 million.

Results: EPS of 5 cents on revenue of $212.8 million.

Outlook: Q3 revenue of $228 million-$230 million, in line with consensus for $228.9 million, and full-year revenue of $910 million-$914 million, above consensus for $897.5 million.

Stock: Shares dropped 5.8% late.

Ulta Beauty

Estimates: Analysts expect the specialty beauty retailer to report second-quarter earnings per share of $1.39, up 21%, on sales of $1.058 billion, also up 21%. Same-store sales and the commentary on the company's loyalty program will also be closely watched.

Results: EPS of $1.43 on revenue of $1.069 billion with comp sales up 14.4%.

Outlook: Q3 EPS of $1.25-$1.30, cautious vs. consensus for $1.29, on revenue of $1.07 billion-$1.09 billion, vs. Wall Street views for $1.075 billion. Full-year comp sales growth is seen at 11%-13%.

Ulta has benefited from limited competition, insulation from e-commerce players like Amazon (AMZN) and greater demand for higher-end beauty products over cosmetics found in drugstores.

Stock: Shares slipped 0.9% late Thursday.


IBD'S TAKE: Among retailer stocks, Vipshop and Ulta Beauty have been the leaders, but here's why you should consider selling Ulta stock.


RELATED:

Will Autodesk Transition Pay Off In Quarterly Earnings?

Splunk Price Target Boosted Ahead Of Earnings As Big Data Roars

Ulta Beauty Earnings After The Close: What To Look For